Balanced news tone
News Sentiment
ROP sentiment intelligence
Roche Holding AG news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
92/100 classification confidence.
directly relevant articles
high-authority source matches
-1.2% over one week, +2.0% over four weeks, trend inactive, and materially above fair value.
Variable Portfolio - Partners International Core Equity Fund's Roche Holding AG(XSWX:ROP) Holding History
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Variable Portfolio - Partners International Core Equity Fund's Roche Holding AG(XSWX:ROP) Holding History
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jul 2026 00:43
- Source
- GuruFocus
Roche (SWX:ROP) Stock May Still Be A Bargain On A 32% Run
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jul 2026 07:00
- Source
- Market source
C4 yourself: $1B second Roche deal evidence of DAC faith
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 09 Apr 2026 07:00
- Source
- BioWorld News
Risdiplam generic drug case: SC rejects Roche plea against Natco pharma
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Oct 2025 07:00
- Source
- Business Standard
Natco Pharma up 6% as Delhi HC clears SMA drug, rejects Roche appeal
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Oct 2025 07:00
- Source
- Business Standard
Roche acquires 89bio for US$3.5bn
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Sep 2025 07:00
- Source
- European Biotechnology Magazine
Is Roche a Buy Now?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 20 Mar 2023 07:00
- Source
- The Motley Fool
Gilead Sciences Names Roche's O'Day as CEO and Chairman
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Dec 2018 08:00
- Source
- thestreet.com
Roche agrees to pay $2.4 billion to buy the rest of Foundation Medicine
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 19 Jun 2018 07:00
- Source
- CNBC
Roche reports deaths of patients taking Hemlibra
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 Mar 2018 07:00
- Source
- BioPharma Dive
Despite trial win, Roche’s new eye drug can’t escape Eylea’s shadow
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Feb 2018 08:00
- Source
- BioPharma Dive
Transnational Roche Selects Escazú Village to House Costa Rican IT Service Center
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Sep 2017 01:13
- Source
- Costa Rica Star News